$NWBO @DCarnival46

#CancerMoonshot today will not only be about glioblastoma, but about the horrible DIPG (diffuse intrinsic pontine glioma) occuring in children and young adults.

You know who got their PIP plan approved last year by the MHRA in the UK? Image
You know who ANNOUNCED a new center of cancer excellence in Sutton in the UK two months ago, 130 miles from Sawston, focusing on DIPG? Image
You know who donated 2.5 million pounds to the center and that Hugh Adams works for them and have helped NWBO meeting british politicians and he wrote the "Pathway to a Cure" report, where politicians urges MHRA and NICE to get DCVax-L to patients? Image
SAME DAY MHRA announced this

"This new funding will accelerate the delivery of cutting-edge treatments like cancer vaccines" Image
One week later the MHRA announced this. Image
The new Quarterly SEC filing says

"We plan to work on preparations for Phase II trials of DCVax-Direct as resources permit."

You know NWBO already had planned DCVax-Direct trials in 2019 targeting DIPG?

nwbio.com/wp-content/upl… Image
Just saying.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with 🇩🇰 The Danish Dude 🇩🇰

🇩🇰 The Danish Dude 🇩🇰 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @FlemmingBruce

Mar 28
$NWBO

Spoofing has continued until the ruling. Probably also naked shorting.

Would market makers be able to continue and hope this will not be revealed during discovery or would they be better of to stop? Image
Image
Image
Read 5 tweets
Mar 26
$NWBO

I have made several AI's concurrently look into all SEC filings, PR's, ASMs and all criticism today on Investorshub into this thesis, and correlating their answers between them:

Was Flaskworks EDEN
included in the
MAA for DCVax-L?

In short? Image
Read 12 tweets
Feb 27
$NWBO

Thanks to @voloda37814097 for this.

🚨 MY FINAL TAKE on MHRA’s MIA Update (UK MIA 54923) & DCVax-L! 🚨

MHRA shifting Advent’s MIA from “Human” to Regulation 17 (Wholesale Distribution) is a BIG SIGNAL for DCVax-L’s path to commercialization. Let’s break it down 🧵👇
1️⃣ What This Means: A Distribution Step
🔹 MHRA updated Advent’s MIA on Feb 28, 2025 from “Human” to “Regulation 17”
🔹 R 17 covers wholesale authorization → Advent may now distribute DCVax-L
🔹 Ties into MHRA’s ATMP framework & post-approval steps → Getting DCVax-L to patients
🚀 Not about manufacturing anymore. About getting DCVax-L out the door!

2️⃣ Approval Imminent?
📍 MHRA has been processing DCVax-L’s MAA since Dec 2023
📍 Feb 20 GMP update for Clean Room C = readiness for production
📍 R 17 now updated → signaling potential post-approval steps
Read 7 tweets
Feb 27
$NWBO

🚨 MY TAKE on Advent’s MIA Update
(Feb 27, 2025)! 🚨
MIA 54923 updated again in under a week—Feb 20 GMP, Feb 27 MIA.

What’s up?
🔹 Facility Upgrades Likely – I’m With ChatGPT ✅ – I think this could signal upgrades at Advent’s Sawston site, like enhancing capacity or tech (e.g., Flaskworks EDEN for DCVax-L). MHRA’s Feb 20 GMP (1-day cert) —new equipment or processes might need swift MIA updates.
🔹 Scope Expansion Possible – Makes Sense ✅ – I believe Advent might be broadening manufacturing for DCVax-L or new products (e.g., in-licensed tech from 2024). MHRA’s Feb update prioritizes timely approvals—expanding authorized activities fits NWBO’s MAA push (Dec 2023).
Read 8 tweets
Feb 19
$NWBO

Is the “New” Murcidencel Trial Actually an Old One? A Closer Look at the Evidence

Recently, a new clinical trial under the name Murcidencel appeared in European clinical trial databases.

🔗 Murcidencel Trial:

(1/🧵)clinicaltrials.eu
Strange Detail: The Murcidencel trial has a start date of 2015 - the same period when an earlier dendritic cell vaccine (DC) trial was conducted.

The old trial, published July 2024, did not specify the vaccine’s name.

🔗 Old Trial (July 2024):

(2/🧵)onlinelibrary.wiley.com
Key Question:
Is the “new” Murcidencel trial actually just an update of the old trial, now formally named under its International Nonproprietary Name (INN)?

Let’s examine the key findings:

(3/🧵)
Read 20 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(